Pharmaceutical News

RSS

SAMHSA develops Metro Briefs on drug-related statistics across the nation

The Substance Abuse and Mental Health Services Administration has developed a series of Metro Briefs providing detailed statistical snapshots of drug- related visits to hospital emergency departments occurring in 11 metropolitan areas across the nation.

25 Apr 2011

U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day

Global malaria control efforts must be significantly scaled up if the world is to reach the goal of reducing malaria deaths to almost zero by 2015, U.N. Secretary-General Ban Ki-moon said in a message on Thursday ahead of World Malaria Day, which is officially observed on Monday, the U.N. News Centre writes.

25 Apr 2011

Research sheds light on molecular movements of neural transporters

A team of scientists from Columbia University College of Physicians and Surgeons and Weill Cornell Medical College has shed light on the molecular workings of transporter proteins, molecular machines embedded in the cell membranes of neurons that modulate the transfer of signals between cells and recycle neurotransmitters.

25 Apr 2011

FDA approves Sanofi Pasteur's meningococcal vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.

25 Apr 2011

AP reports on Global Fund malaria drug thefts, issues correction

The Associated Press on Wednesday published an article reporting that hundreds of millions of dollars of malaria medication had been stolen from the Global Fund to Fight AIDS, Tuberculosis and Malaria, but later issued a correction.

25 Apr 2011

Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment

Sequella, a clinical-stage pharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, and Maxwell Biotech Venture Fund announced their agreement to complete the clinical development and commercialize SQ109 for treatment of tuberculosis in the Russian Federation and neighboring Commonwealth of Independent States countries, including Armenia, Azerbaijan, Belorussia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, and Ukraine.

25 Apr 2011

Nano Terra, Kadmon sign deal to license novel product candidates

Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra's drug discovery platform, Pharmacomer Technology.

25 Apr 2011

Creative approach can tackle bacterial infections in patients with cystic fibrosis

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

25 Apr 2011

Californians for Patient Care reminds parents about affordable infants' immunizations

In advance of National Infant Immunization Week, observed April 23-30, Californians for Patient Care reminds parents there are affordable immunizations available for their infants in their communities.

25 Apr 2011

Bayer's birth control pills may increase risk of venous thromboembolism

The following release is being issued by law firms RodaNast, P.C.; Levin, Fishbein, Sedran & Berman and Feldman & Pinto: According to two new studies published in the online edition of the British Medical Journal, Bayer's birth control pills Yaz and Yasmin, containing a new progestin drospirenone, carry up to triple the risk of serious blood clots over traditional pills containing the progestin levonorgestrel.

25 Apr 2011

Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease

The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.

24 Apr 2011

Rite Aid reduces price of whooping cough vaccine for children in California

Parents in California can now get their children vaccinated against whooping cough at more than 500 Rite Aid pharmacies for the newly lowered price of $57.99. By July 1, when a new state law takes effect requiring proof of vaccination for all students entering grades 7 through 12, nearly all of the approximately 600 California Rite Aid locations will be able to vaccinate walk-in patients or by appointment.

22 Apr 2011

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Daiichi Sankyo Company, Limited, announced today that the company has received its first marketing approval for LIXIANA 15 mg and 30 mg tablets, by the Ministry of Health, Labor and Welfare in Japan.

22 Apr 2011

Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility

Luitpold Pharmaceuticals, Inc. today announced that it has temporarily suspended distribution of all of its drug products manufactured at its Shirley, New York facility and marketed by its American Regent, Inc. subsidiary and Animal Health Division.

22 Apr 2011

United Water and NCPA embark on an effort to encourage safe disposal of unused medications

United Water and the National Community Pharmacists Association (NCPA) announced a partnership today to encourage people throughout the United States to properly dispose of their unused or expired medications in an environmentally-friendly manner. A major part of the campaign will center around the NCPA's website dedicated to the program - www.DisposeMyMeds.org - that directs people to their local independent pharmacy where they can drop off their unused medications.

22 Apr 2011

Decision Resources: 63% of neurologists select Tysabri as effective MS treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed U.S. neurologists selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.

22 Apr 2011

NPR: 3 in 4 prescriptions are for generic drugs

The brand-name pharmaceutical industry has a drug problem. All 10 of the most prescribed medicines in the U.S. last year were generics, led by the defending champion generic equivalents of Vicodin.

22 Apr 2011

Fleming ramps up production of ThyroShield to meet increased domestic and international demand

Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.

22 Apr 2011

Researchers discover new compound to fight against shingles

Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles-a condition that affects up to 30 percent of Americans, mostly elderly, and for which no specific treatment exists.

22 Apr 2011

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.

22 Apr 2011

Pharmaceutical News

SAMHSA develops Metro Briefs on drug-related statistics across the nation

U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day

Research sheds light on molecular movements of neural transporters

FDA approves Sanofi Pasteur's meningococcal vaccine

AP reports on Global Fund malaria drug thefts, issues correction

Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment

Nano Terra, Kadmon sign deal to license novel product candidates

Creative approach can tackle bacterial infections in patients with cystic fibrosis

Californians for Patient Care reminds parents about affordable infants' immunizations

Bayer's birth control pills may increase risk of venous thromboembolism

Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease

Rite Aid reduces price of whooping cough vaccine for children in California

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility

United Water and NCPA embark on an effort to encourage safe disposal of unused medications

Decision Resources: 63% of neurologists select Tysabri as effective MS treatment

NPR: 3 in 4 prescriptions are for generic drugs

Fleming ramps up production of ThyroShield to meet increased domestic and international demand

Researchers discover new compound to fight against shingles

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News